How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Automobile and Transportation · Forecast 2027–2033
In Vivo Imaging System Market
- By Imaging Modality: Fluorescence Imaging Systems, Bioluminescence Imaging Systems, X-ray Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems
- By Application: Oncology Research, Cardiovascular Research, Neurological Research, Infectious Disease Research, Drug Discovery and Development
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Clinical Research Organizations, Contract Research Organizations (CROs)
- By Technology: Optical Imaging, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography (PET)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fluorescence Imaging Systems leads By Imaging Modality at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the In Vivo Imaging System Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Imaging Modality 5
Application 5
End User 4
Technology 4
Companies profiled
PerkinElmer Inc.
Bruker Corporation
Miltenyi Biotec
FUJIFILM VisualSonics Inc.
SOPHIA GENETICS
BioSpace
Mediso Medical Imaging Systems
VisEn Medical Inc.
Spectrum Instruments
Biospace Lab
Magnetic Insight Inc.
Caliper Life Sciences (now part of PerkinElmer)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →PerkinElmer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bruker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Miltenyi Biotec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →FUJIFILM VisualSonics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →SOPHIA GENETICS
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BioSpace
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mediso Medical Imaging Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →VisEn Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Spectrum Instruments
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Biospace Lab
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Magnetic Insight Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Caliper Life Sciences (now part of PerkinElmer)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Aspect Imaging
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Imalytics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →InVivo Analytics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,532M by 2033 · 7.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fluorescence Imaging Systems42.3
- Bioluminescence Imaging Systems18.0
- X-ray Imaging Systems19.5
- Magnetic Resonance Imaging (MRI) Systems9.4
- Computed Tomography (CT) Systems10.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$838.6M → $1,350M · 6.1%
Europe$584.5M → $1,016M · 7.2%
Asia Pacific$533.7M → $917.5M · 7.0%
Latin America$330.4M → $534.7M · 6.2%
Middle East and Africa$254.1M → $507.8M · 9.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.462026
7.452027
7.482028
7.492029
7.502030
7.512031
7.512032
7.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- PerkinElmer Inc.19.6
- Bruker Corporation21.0
- Miltenyi Biotec8.6
- FUJIFILM VisualSonics Inc.8.3
- SOPHIA GENETICS5.9
- BioSpace8.5
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Imaging Modality13.3%
Application23.9%
End User27.7%
Technology35.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.2
- Europe23.5
- Asia Pacific21.2
- Latin America12.4
- Middle East and Africa11.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| PerkinElmer Inc. | 97 | 96 | 82 | 98 | 90 | 86 | 92 |
| Bruker Corporation | 92 | 78 | 81 | 84 | 78 | 93 | 84 |
| Miltenyi Biotec | 86 | 81 | 80 | 87 | 86 | 77 | 83 |
| FUJIFILM VisualSonics Inc. | 62 | 58 | 80 | 67 | 60 | 78 | 68 |
| SOPHIA GENETICS | 67 | 71 | 53 | 58 | 69 | 58 | 63 |
| BioSpace | 70 | 63 | 50 | 67 | 63 | 63 | 63 |
| Mediso Medical Imaging Systems | 41 | 49 | 63 | 50 | 41 | 66 | 52 |
| VisEn Medical Inc. | 60 | 51 | 51 | 57 | 51 | 41 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- PerkinElmer Inc.
- Bruker Corporation
- Miltenyi Biotec
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| PerkinElmer Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Bruker Corporation | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Miltenyi Biotec | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| FUJIFILM VisualSonics Inc. | ✓ | − | ✓ | ◐ | − | ◐ |
| SOPHIA GENETICS | − | ✓ | ◐ | ◐ | ◐ | ◐ |
| BioSpace | ◐ | − | − | ◐ | ◐ | ◐ |
| Mediso Medical Imaging Systems | − | − | ◐ | − | − | − |
| VisEn Medical Inc. | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1PerkinElmer Inc.92
2Bruker Corporation84
3Miltenyi Biotec83
4FUJIFILM VisualSonics Inc.68
5SOPHIA GENETICS63
6BioSpace63
7Mediso Medical Imaging Systems52
8VisEn Medical Inc.52
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
PerkinElmer Inc.Bruker CorporationMiltenyi Biotec
Challenger1
Strong scale, closing on the leaders.
FUJIFILM VisualSonics Inc.
Contender2
Focused players with pockets of strength.
SOPHIA GENETICSBioSpace
Niche2
Specialists in a single segment or region.
Mediso Medical Imaging SystemsVisEn Medical Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Imaging Modality in North America, then scale across In Vivo Imaging System Market — a $267M beachhead inside a $3.53B market.
Beachhead (SOM)$267Mobtainable near-term
Serviceable (SAM)$1.47Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Fluorescence Imaging Systems
Best fit — highest urgency & budget in Imaging Modality.
Economic buyer79 fit
Bioluminescence Imaging Systems
Strong fit — clear ROI and a fast path to value.
End user67 fit
X-ray Imaging Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Imaging Modality in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel25%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Imaging Modality leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win In Vivo Imaging System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation14%
Closed-won7%
$17.4KCAC
$100KLTV
5.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
In Vivo Imaging System Market is a resilient opportunity — $4.63B by 2033, compounding at 3.6%.
TAM · 2025$3.49Btoday
TAM · 2033$4.63Bforecast
CAGR3.6%2027–2033
Cumulative$36.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.63BTotal addressable market
SAM$1.58BServiceable available market
SOM$266MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.6% CAGR
Demand compounds through 2033, outpacing GDP across Imaging Modality.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Imaging Modality moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.63BLarge & growingTAM by 2033 at 3.6% CAGR
$1.58BServiceable nowreachable with today’s model
$266MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.61BBear2.3% CAGR
$4.63BBase3.6% CAGR
$5.92BBull4.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
In Vivo Imaging System Market — a $3.31B market by 2033. Plan: grow share from 8.4% to 13.0%.
Market size · 2033$3.31Btotal addressable
Market CAGR11.2%2027–2033
Target share13.0%from 8.4% today
Revenue ambition$430Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.4% | 13.0% | Behind |
| Revenue | $301M | $430M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 31.5% | 38.7% | On track |
| Customer retention | 86.5% | 94.7% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Imaging Modality
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Imaging Modality share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $59M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Imaging Modality leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the In Vivo Imaging System Market conversation — a $6.95B market you can size, segment and defend in minutes.
Market size · 2033$6.95Btotal opportunity
Growth11.1%CAGR to 2033
Addressable buyers1,183+accounts in scope
Typical ROI6.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Imaging Modality
Goal Grow share in Imaging Modality
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.8×return on cost, year one
< 4 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
PerkinElmer Inc.Bruker CorporationMiltenyi BiotecFUJIFILM VisualSonics Inc.SOPHIA GENETICSBioSpaceMediso Medical Imaging SystemsVisEn Medical Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your In Vivo Imaging System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
In Vivo Imaging System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Automobile and Transportation · scroll →Invisible Paint Protection Film Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportInvisible Car Jackets Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportInvisible Car Film Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportInvisible Car Cover Market
Market size, share, segmentation and regional forecast.
$408M market · 2025 base year
View reportInvestment Casting Automotive Parts Market
Market size, share, segmentation and regional forecast.
$998M market · 2025 base year
View reportInverted Tooth Drive Chains Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportInverted Front Fork Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportIn-vehicle Voice Control Systems Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportIn-vehicle Video Player System Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportInvehicle Telematics Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportIn-vehicle Router for Public Safety Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportIn-vehicle PoC Inductors Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.